NCT03677492已完成不适用
Cytochalasin D Supplementation to ICSI Handling Medium
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 3
- 主要终点
- Oocyte survival rate
研究概览
简要总结
Vienna Consensus has identified 10% damage rate after ICSI as a competency value. Despite the highest quality embryologists doing ICSI, degeneration sometimes occurs due to oocyte factors such as the fragile membrane, etc. Cytochalasin D serves to facilitate spindle or pronuclear transfer procedures helping to reduce the damage rate with no harm reported. Using Cytochalasin D during ICSI could serve to rescue some oocytes from the degeneration allowing for more chances of viable zygotes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 42 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •ICSI indicated participants
排除标准
- 未提供
研究组 & 干预措施
Handling Medium Supplemented with Cytochalasin D
Experimental
干预措施: Medium Supplemented with Cytochalasin D (Other)
Handling Medium as it is.
No Intervention
结局指标
主要结局
Oocyte survival rate
时间窗: 6 days of culture
次要结局
- Fertilization rate(6 days of culture)
- Embryo utilization rate(6 days of culture)
- Blastocyst formation rate(6 days of culture)
- Implantation rate(7 weeks)
- Ongoing pregnancy rate(12 weeks)
- Clinical pregnancy rate(three months)
研究者
Muhammad Fawzy
IVF Lab Director
Ibn Sina Hospital
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin BInfertilityNCT03663634Ibn Sina Hospital987
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)InfertilityNCT03678584Ibn Sina Hospital300
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)InfertilityNCT03678818Ibn Sina Hospital300
已完成
不适用
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)InfertilityNCT03678597Ibn Sina Hospital300
已完成
不适用
Decompressive Hemicraniectomy in Intracerebral HemorrhageCerebral HemorrhageNCT02258919Insel Gruppe AG, University Hospital Bern201